international.
.

.
understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study..
marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".
like dailymail .
here are 4 mass. biotechs making noise at the ash conference so far.
. shuki sadeh .
.
.